For example, VU6004909 attenuated nucleus accumbens hyperactivity, suggesting that an mGlu1 PAM may ameliorate motivational deficits in schizophrenia (Kirkpatrick et al., 2006). This evidence concerns the gene GRM1 and schizophrenia.